trending Market Intelligence /marketintelligence/en/news-insights/trending/_46Kik-F1qzG-YvtMpq3BQ2 content esgSubNav
In This List

Riverside invests in Spanish pharmaceutical ingredient maker

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Riverside invests in Spanish pharmaceutical ingredient maker

Lower-middle-market private equity firm Riverside Partners LLC, doing business as The Riverside Co., made an undisclosed investment in Spanish active pharmaceutical ingredients producer HealthTech BioActives SL.

The transaction includes the 140 employees of HealthTech, which is a carve-out of Spain-based international pharmaceutical company Ferrer.

KPMG was carve-out and financial adviser to Riverside, with Garrigues and Advocatenkantoor Parmentier offering legal and tax counsel. A&O was a legal adviser for the financing process, while Dextra Corporate was the exclusive buy-side M&A adviser, and PWC was ESG and buy-side debt adviser. Roland Berger was commercial adviser, and financing was provided by LGT Private Debt.

Deloitte was Ferrer's financial, legal, tax and exclusive sell-side M&A adviser.